-
1 Comment
Access Bio, Inc is currently in a long term uptrend where the price is trading 56.1% above its 200 day moving average.
From a valuation standpoint, the stock is 100.0% cheaper than other stocks from the Other sector with a price to sales ratio of 0.0.
Access Bio, Inc's total revenue rose by 833.7% to $91B since the same quarter in the previous year.
Its net income has increased by 714.5% to $47B since the same quarter in the previous year.
Finally, its free cash flow grew by 77976.9% to $33B since the same quarter in the previous year.
Based on the above factors, Access Bio, Inc gets an overall score of 5/5.
None
Here's how to backtest a trading strategy or backtest a portfolio for 950130.KO using our backtest tool. PyInvesting provides the backtesting software for you to backtest your investment strategy. Our backtest software is written using Python code and allows you to backtest stock, backtest etf, backtest options, backtest crypto and backtest forex online. Our backtesting Python framework is highly robust and gives you a realistic simulation of how your strategy would have performed in the past using backtest data.
© PyInvesting 2025
